HOB Biotech Group Corp.,Ltd (SHA:688656)
101.39
+2.39 (2.41%)
Oct 23, 2026, 3:00 PM CST
SHA:688656 Revenue
HOB Biotech Group Corp.,Ltd had revenue of 116.91M CNY in the quarter ending June 30, 2026, with 4.33% growth. This brings the company's total for the last twelve months to 404.51M, up 3.94% year-over-year. In the year 2025, HOB Biotech Group Corp.,Ltd had annual revenue of 398.40M, down -0.98%. That makes HOB Biotech Group Corp.,Ltd the 26,508th largest company in the world by revenue and 4,654th in China.
Revenue (ttm)
404.51M
Revenue Growth
+3.94%
P/S Ratio
15.72
Revenue / Employee
770.49K
Employees
525
Market Cap
6.36B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHA:688656 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 398.40M | -3.94M | -0.98% |
| Dec 31, 2024 | 402.34M | 7.93M | 2.01% |
| Dec 31, 2023 | 394.41M | 74.01M | 23.10% |
| Dec 31, 2022 | 320.39M | 2.68M | 0.84% |
| Dec 31, 2021 | 317.71M | 95.85M | 43.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shinva Medical Instrument | 10.11B |
| Edan Instruments | 2.11B |
| INKON Life Technology | 2.06B |
| Shenzhen YHLO Biotech | 1.89B |
| Guangzhou Wondfo Biotech Co.,Ltd | 1.88B |
| Beijing Wandong Medical Technology | 1.43B |
| BMC Medical | 1.38B |
| Xiangyu Medical Co.,Ltd | 781.87M |